Terumo Corp. (OTCMKTS:TRUMY) Sees Large Increase in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 90,572 shares, a growth of 96.3% from the July 30th total of 46,134 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 104,726 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy”.

Terumo Price Performance

TRUMY stock opened at $15.84 on Monday. The stock has a market cap of $23.37 billion, a P/E ratio of 22.31 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. Terumo has a twelve month low of $12.08 and a twelve month high of $18.83. The company’s 50 day moving average is $14.61 and its two-hundred day moving average is $13.86.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.55%. The business had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Research analysts expect that Terumo will post 0.7 earnings per share for the current fiscal year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.